Actively Recruiting

Phase 2
Age: 18Years - 68Years
All Genders
NCT06830629

A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease

Led by Maze Therapeutics · Updated on 2026-04-17

56

Participants Needed

81

Research Sites

81 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This is purpose of this study is to evaluate the safety, tolerability, and effect on Albuminuria of MZE829 in Adults with APOL1 Kidney Disease

CONDITIONS

Official Title

A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease

Who Can Participate

Age: 18Years - 68Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • APOL1 high risk genotype of G1/G1, G2/G2, or G1/G2
  • Chronic kidney disease with persistent albuminuria
  • Age between 18 and 68 years
Not Eligible

You will not qualify if you...

  • History of organ or bone marrow transplantation
  • History of cancer within past 2 years except treated non-melanoma skin cancer, stage 0 cervical cancer, or stage 1 prostate cancer
  • Conditions that may affect drug absorption, such as previous bariatric surgery
  • Diagnosis of Type I diabetes
  • Pregnant or currently nursing

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 81 locations

1

Research Site

Decatur, Alabama, United States, 35601

Actively Recruiting

2

Research Site

Huntsville, Alabama, United States, 35805

Actively Recruiting

3

Research Site

Montgomery, Alabama, United States, 36106

Actively Recruiting

4

Research Site

Montgomery, Alabama, United States, 36117

Actively Recruiting

5

Research Site

Granada Hills, California, United States, 91344

Actively Recruiting

6

Research Site

Bloomfield, Connecticut, United States, 06112

Actively Recruiting

7

Research Site

Atlantis, Florida, United States, 33462

Actively Recruiting

8

Research Site

Brandon, Florida, United States, 33511

Actively Recruiting

9

Research Site

Brooksville, Florida, United States, 34613

Actively Recruiting

10

Research Site

Hollywood, Florida, United States, 33024

Actively Recruiting

11

Research Site

Melbourne, Florida, United States, 32901

Actively Recruiting

12

Research Site

Miami Lakes, Florida, United States, 33014

Actively Recruiting

13

Research Site

Orlando, Florida, United States, 32822

Actively Recruiting

14

Research Site

Atlanta, Georgia, United States, 30309

Actively Recruiting

15

Research Site

College Park, Georgia, United States, 30349

Actively Recruiting

16

Research Site

Cordele, Georgia, United States, 31015

Actively Recruiting

17

Research Site

Lithia Springs, Georgia, United States, 30122

Actively Recruiting

18

Research Site

Macon, Georgia, United States, 31210

Actively Recruiting

19

Research Site

Riverdale, Georgia, United States, 30274

Actively Recruiting

20

Research Site

Riverdale, Georgia, United States, 30296

Actively Recruiting

21

Research Site

Savannah, Georgia, United States, 31406

Actively Recruiting

22

Research Site

Snellville, Georgia, United States, 30078

Actively Recruiting

23

Research Site

Chicago, Illinois, United States, 60616

Actively Recruiting

24

Research Site

Chicago, Illinois, United States, 60643

Actively Recruiting

25

Research Site

Kansas City, Kansas, United States, 66112

Actively Recruiting

26

Research Site

Bowling Green, Kentucky, United States, 42101

Actively Recruiting

27

Research Site

Louisville, Kentucky, United States, 40205

Actively Recruiting

28

Research Site

Arnold, Maryland, United States, 21012

Actively Recruiting

29

Research Site

Lutherville, Maryland, United States, 21093

Actively Recruiting

30

Research Site

Oxon Hill, Maryland, United States, 20745

Actively Recruiting

31

Research Site

Dearborn, Michigan, United States, 48126

Actively Recruiting

32

Research Site

Flint, Michigan, United States, 48503

Actively Recruiting

33

Research Site

Pontiac, Michigan, United States, 48341

Actively Recruiting

34

Research Site

Saint Joseph, Michigan, United States, 49085

Actively Recruiting

35

Research Site

Shelby, Michigan, United States, 48092

Actively Recruiting

36

Research Site

Minneapolis, Minnesota, United States, 55404

Actively Recruiting

37

Research Site

Tupelo, Mississippi, United States, 38801

Actively Recruiting

38

Research Site

City of Saint Peters, Missouri, United States, 63376

Actively Recruiting

39

Research Site

St Louis, Missouri, United States, 63103

Actively Recruiting

40

Research Site

Las Vegas, Nevada, United States, 89107

Actively Recruiting

41

Research Site

Buffalo, New York, United States, 14203

Actively Recruiting

42

Research Site

Laurelton, New York, United States, 11413

Actively Recruiting

43

Research Site

Maspeth, New York, United States, 11378

Actively Recruiting

44

Research Site

New York, New York, United States, 10021

Actively Recruiting

45

Research Site

Newburgh, New York, United States, 12550

Actively Recruiting

46

Research Site

Durham, North Carolina, United States, 27708

Actively Recruiting

47

Research Site

Fayetteville, North Carolina, United States, 28304

Actively Recruiting

48

Research Site

Greensboro, North Carolina, United States, 27405

Actively Recruiting

49

Research Site

Shelby, North Carolina, United States, 28150

Actively Recruiting

50

Research Site

Cincinnati, Ohio, United States, 45267

Actively Recruiting

51

Research Site

Cleveland, Ohio, United States, 44106

Actively Recruiting

52

Research Site

Cleveland, Ohio, United States, 44195

Actively Recruiting

53

Research Site

Columbus, Ohio, United States, 43215

Actively Recruiting

54

Research Site

Ardmore, Oklahoma, United States, 73401

Actively Recruiting

55

Research Site

Philadelphia, Pennsylvania, United States, 19104

Actively Recruiting

56

Research Site

Philadelphia, Pennsylvania, United States, 19107

Actively Recruiting

57

Research Site

Upland, Pennsylvania, United States, 19013

Actively Recruiting

58

Research Site

Columbia, South Carolina, United States, 29203

Actively Recruiting

59

Research Site

Spartanburg, South Carolina, United States, 29302

Actively Recruiting

60

Research Site

Spartanburg, South Carolina, United States, 29306

Actively Recruiting

61

Research Site

Chattanooga, Tennessee, United States, 37404

Actively Recruiting

62

Research Site

Dallas, Texas, United States, 75230

Actively Recruiting

63

Research Site

Dallas, Texas, United States, 75246

Actively Recruiting

64

Research Site

Greenville, Texas, United States, 75402

Actively Recruiting

65

Research Site

Houston, Texas, United States, 77030

Actively Recruiting

66

Research Site

Houston, Texas, United States, 77054

Actively Recruiting

67

Research Site

Houston, Texas, United States, 77099

Actively Recruiting

68

Research Site

McKinney, Texas, United States, 75069

Actively Recruiting

69

Research Site

San Antonio, Texas, United States, 78251

Actively Recruiting

70

Research Site

Shenandoah, Texas, United States, 77384

Actively Recruiting

71

Research Site

Sherman, Texas, United States, 75092

Actively Recruiting

72

Research Site

Norfolk, Virginia, United States, 23504

Actively Recruiting

73

Research Site

Créteil, France, 94010

Actively Recruiting

74

Research Site

Lyon, France, 69347

Actively Recruiting

75

Research Site

Paris, France, 75015

Actively Recruiting

76

Research Site

Paris, France, 75020

Actively Recruiting

77

Research Site

Saint-Ouen, France, 93400

Actively Recruiting

78

Research Site

Leicester, United Kingdom, LE5 4PW

Actively Recruiting

79

Research Site

London, United Kingdom, NW3 2QG

Actively Recruiting

80

Research Site

London, United Kingdom, SE19RT

Actively Recruiting

81

Research Site

London, United Kingdom, SE59RS

Actively Recruiting

Loading map...

Research Team

M

Maze Therapeutics

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease | DecenTrialz